OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients
about
Hemicrania continua: clinical review, diagnosis and management.Action mechanisms of Onabotulinum toxin-A: hints for selection of eligible patients.Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal.Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations.Hemicrania Continua.
P2860
OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients
@ast
OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients
@en
type
label
OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients
@ast
OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients
@en
prefLabel
OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients
@ast
OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients
@en
P2093
P2860
P1476
OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients
@en
P2093
Fernando Correia
Sarah Miller
Susie Lagrata
P2860
P2888
P356
10.1186/S10194-015-0502-Z
P577
2015-03-05T00:00:00Z
P5875
P6179
1037571616